778 related articles for article (PubMed ID: 36174227)
21. Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).
Helms HCC; Kristensen M; Saaby L; Fricker G; Brodin B
Handb Exp Pharmacol; 2022; 273():151-183. PubMed ID: 33367937
[TBL] [Abstract][Full Text] [Related]
22. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
Crawford L; Rosch J; Putnam D
J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
[TBL] [Abstract][Full Text] [Related]
23. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
24. Adsorptive-mediated brain delivery systems.
Lu W
Curr Pharm Biotechnol; 2012 Sep; 13(12):2340-8. PubMed ID: 23016640
[TBL] [Abstract][Full Text] [Related]
25. Nanobiotechnology-based drug delivery in brain targeting.
Dinda SC; Pattnaik G
Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
[TBL] [Abstract][Full Text] [Related]
26. Harnessing the capacity of cell-penetrating peptides for drug delivery to the central nervous system.
Kang T; Gao X; Chen J
Curr Pharm Biotechnol; 2014; 15(3):220-30. PubMed ID: 24938893
[TBL] [Abstract][Full Text] [Related]
27. Recent Advances in Delivery of Peptide and Protein Therapeutics to the Brain.
Arora S; Bajaj T; Kumar J; Goyal M; Singh A; Singh C
J Pharmacol Exp Ther; 2024 Jan; 388(1):54-66. PubMed ID: 37977811
[TBL] [Abstract][Full Text] [Related]
28. Transcellular brain drug delivery: A review on recent advancements.
Azarmi M; Maleki H; Nikkam N; Malekinejad H
Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
[TBL] [Abstract][Full Text] [Related]
29. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.
Wang JZ; Xiao N; Zhang YZ; Zhao CX; Guo XH; Lu LM
Pharmacol Res; 2016 Feb; 104():124-31. PubMed ID: 26747400
[TBL] [Abstract][Full Text] [Related]
30. Strategies for Structural Modification of Small Molecules to Improve Blood-Brain Barrier Penetration: A Recent Perspective.
Xiong B; Wang Y; Chen Y; Xing S; Liao Q; Chen Y; Li Q; Li W; Sun H
J Med Chem; 2021 Sep; 64(18):13152-13173. PubMed ID: 34505508
[TBL] [Abstract][Full Text] [Related]
31. Designing peptide nanoparticles for efficient brain delivery.
Duro-Castano A; Moreira Leite D; Forth J; Deng Y; Matias D; Noble Jesus C; Battaglia G
Adv Drug Deliv Rev; 2020; 160():52-77. PubMed ID: 33031897
[TBL] [Abstract][Full Text] [Related]
32. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
33. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
34. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
35. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
36. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
37. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
38. The blood-brain barrier: structure, regulation, and drug delivery.
Wu D; Chen Q; Chen X; Han F; Chen Z; Wang Y
Signal Transduct Target Ther; 2023 May; 8(1):217. PubMed ID: 37231000
[TBL] [Abstract][Full Text] [Related]
39. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
40. Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis.
Abdul Razzak R; Florence GJ; Gunn-Moore FJ
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]